Medical Devices
The latest news about Medical Devices: headlines, AI summaries and the full story from every source.
- Alcon Announces Full-Year Sales Guidance and Strategic Growth Drivers
- Carlsmed Reports 65% Revenue Growth and Raises Full Year 2026 Guidance
- BionicM Secures JPY 710 Million in Series B Funding to Fuel U.S. Expansion
- FDA Issues Not Approvable Letter for NovoCure's Optune Mya
- Beta Bio Reports Q3 2026 Net Sales of $35.5 Million and Raises Revenue Guidance
- Delcath Systems Announces Record Q3 Revenue and Provides 2026 Guidance
- Intuitive Surgical Q3 2026 Performance: Analyzing Robot Placements and Recurring Revenue Growth
- Enovis Corporation Raises 2026 EPS Guidance and Announces $200 Million Share Repurchase Program
- Cerus Announces Positive Phase III REDeS Study Results and Strategic Shift to Kit-Based Model
- Rockwell Medical to Acquire Majority of Vantive Hemodialysis Business Assets
- FDA Grants 510(k) Clearance to Roche's cobas eplex Respiratory Pathogen Panel
- Profound Medical Partners with Cook Medical to Expand U.S. Distribution of TULSA-PRO System
- Johnson & Johnson Reports 94% Success Rate in Clinical Trial for Shockwave Javelin Catheter
- Johnson & Johnson Reports Lower Mortality Rates for Impella Heart Pump Support
- Fujifilm Subsidiary Fujifilm Sonosite Awarded Up to $958 Million U.S. Defense Contract
- Glaukos Raises 2026 Sales Forecast and Sets $1 Billion Target for 2027
- Boston Scientific Shares Fall After Cyberattack Impacts Sales and Earnings Guidance
- JP Morgan Downgrades Boston Scientific to Neutral, Lowers Price Target
- Companion Spine Completes Integration of Paradigm Spine to Unify Global Spinal Solutions Portfolio
- Beta Bionics Projects 2026 Revenue Between $124M and $126M Following FDA Clearance for Mint Patch Pump
- Abbott Laboratories Announces Third-Quarter Results and Plan to Spin Off Nutrition Segment
- Abbott Announces Nutrition Business Spin-off to Focus on High-Margin Medical Technologies
- Abbott Laboratories Reports Q3 2026 Growth Driven by Diagnostics and Medical Devices
- Johnson & Johnson Raises Full-Year Sales Outlook Amid Strong Pharmaceutical Growth
- Johnson & Johnson Reports Strong Earnings Amid Geopolitical Challenges
- FDA Issues Safety Alert for Philips Lumify Ultrasound Due to Software Issue
- AngioDynamics Exceeds Q1 Revenue and EPS Estimates
- Cooper Companies Director Lawrence Kurzius Buys $539,100 Worth of Shares
- Medtronic's High Dividend Yield and Strong Q1 Results Attract Attention Despite Stock Struggles
- U.S.-China Trade Negotiations to Reveal Details Next Week, Says USTR Greer
- FDA advisory panel endorses GRAIL's Galleri as multi-cancer early detection blood test
- MiniMed Reports Strong Q1 Results but Faces Cash Flow Challenges
- Abbott Laboratories and Intuitive Surgical: Revenue Growth Trends Highlight Stability vs. Expansion
- Wall Street's Growing Optimism Toward Abbott Laboratories
- Edwards Lifesciences Outlines TAVR Expansion and Future Revenue Growth
- Wall Street's Growing Optimism Toward Abbott Laboratories
- Xenetic Biosciences Acquires Santersus to Expand Therapeutic Platform
- Medtronic Outlines Growth Drivers: AI Integration, Ablation Technologies and Strategic M&A
- Apollo Global Management in Talks to Acquire Johnson & Johnson’s DePuy Synthes Orthopedics Unit
- Apollo Rumored to Be in Talks for $20 Billion Acquisition of J&J's Orthopaedics Unit
- Enovis Insider Oliver Engert Buys Over 7,500 Shares in Recent Transactions
- Boston Scientific's Cyberattack Disrupts Guidance Despite Strong Demand
- MiniMed Reports Strong Growth as New Pump Line Gains Traction
- Cooper Companies' Shares Drop Over 13% After Disappointing Earnings Report
- Axogen Acquires BioCircuit for $200 Million to Expand Sutureless Nerve Repair Technology
- Pulse Biosciences Shares Rise on Analyst Initiation of Coverage
- Kimball Electronics Reports Q4 Results and Fiscal 2027 Guidance
- Cooper Companies Stock Drops Over 13% After Disappointing Earnings Report
- Jim Cramer Analyzes Medtronic Amid Strong Growth and Upcoming Diabetes Division Spin-Off
- Oura Shares Key Financials and Regulatory Developments Ahead of IPO